BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12960253)

  • 1. The main function of IL-2 is to promote the development of T regulatory cells.
    Malek TR
    J Leukoc Biol; 2003 Dec; 74(6):961-5. PubMed ID: 12960253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function.
    de la Rosa M; Rutz S; Dorninger H; Scheffold A
    Eur J Immunol; 2004 Sep; 34(9):2480-8. PubMed ID: 15307180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
    Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
    Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
    Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
    Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
    Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
    Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
    Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.
    Tsaknaridis L; Spencer L; Culbertson N; Hicks K; LaTocha D; Chou YK; Whitham RH; Bakke A; Jones RE; Offner H; Bourdette DN; Vandenbark AA
    J Neurosci Res; 2003 Oct; 74(2):296-308. PubMed ID: 14515359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.
    Harnaha J; Machen J; Wright M; Lakomy R; Styche A; Trucco M; Makaroun S; Giannoukakis N
    Diabetes; 2006 Jan; 55(1):158-70. PubMed ID: 16380489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-)two to tango.
    Scheffold A; Hühn J; Höfer T
    Eur J Immunol; 2005 May; 35(5):1336-41. PubMed ID: 15827965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.
    Fehérvári Z; Sakaguchi S
    Int Immunol; 2004 Dec; 16(12):1769-80. PubMed ID: 15520045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
    Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
    Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
    Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
    J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion.
    Cambos M; Bélanger B; Jacques A; Roulet A; Scorza T
    Int J Parasitol; 2008 Feb; 38(2):229-38. PubMed ID: 17868677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.
    van Amelsfort JM; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
    Arthritis Rheum; 2004 Sep; 50(9):2775-85. PubMed ID: 15457445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.